Futuximab

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity[1].

Product Specifications

CAS Number

[1310460-85-5]

UNSPSC

12352203

Target

EGFR

Type

Inhibitory Antibodies

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/futuximab.html

Purity

98.09

Solubility

10 mM in DMSO

Smiles

[Futuximab]

Molecular Weight

(146.28 kDa)

References & Citations

[1]Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138 (3) :489-498.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-24055IR 0.1 mL

Mouse Monoclonal MCM3 Antibody (MCM3/3221) [DyLight 755]

Ask

View Details

50035086 1.0 µg

Vom1r48 3'UTR Lenti-reporter-Luc Vector

Ask

View Details

AHF99301 100 μg

Recombinant Human PTH1R Protein, C-His (Active)

Ask

View Details

HY-P85901 1 Each

Cytokeratin 15 Antibody (YA5593, Mouse)

Ask

View Details

bs-9023R-BF594 100 µL

IQCK Polyclonal Antibody, AbBy Fluor™ 594 Conjugated

Ask

View Details

CRJ8685-01 15 nmol

CDK11A siRNA (Human)

Ask

View Details